Trials that use: Odds ratio
New to this method? Read the tutorial →
2,963 results
- A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma: primary…
- A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy: primary endpoint results, effect estimate with confidence interval,…
- A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval,…
- A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy: primary endpoint results, effect estimate with…
- A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib:…
- A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC): Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker…
- A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma: primary endpoint results, effect estimate with…
- A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase II Trial of Regadenoson in Sickle Cell Anemia: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Regadenoson in Sickle Cell Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01788631).
- A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS): Complete Statistical AnalysisIndependent statistical analysis of A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS): primary endpoint results, effect estimate with confidence…
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study to Assess the Lot-to-lot Consistency of GSK’s Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK’s Influenza D-QIV Vaccine in Healthy Non-pregnant Women.: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone…
- A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Pilot Study Assessing EmSam in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study Assessing EmSam in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535262).
- A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Pilot Study of Acupuncture Treatment for Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Acupuncture Treatment for Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00797732).
- A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02185040).
- A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Pilot Study of Daptomycin for Antimicrobial Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Daptomycin for Antimicrobial Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00572260).
- A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Pilot Study of Suvorexant for Insomnia in Parkinson Disease: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Suvorexant for Insomnia in Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02729714).
- A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pilot Study on Diurnal Variation: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study on Diurnal Variation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01806051).
- A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine: Complete Statistical AnalysisIndependent statistical analysis of A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093: Complete Statistical AnalysisIndependent statistical analysis of A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304): Complete Statistical AnalysisIndependent statistical analysis of A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Positive Psychology Intervention for Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Positive Psychology Intervention for Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03637699).
- A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.: Complete Statistical AnalysisIndependent statistical analysis of A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical…